New Gene Correction Clinical Trial for Sickle Cell Disease Expanding to Children as Young as 12
A clinical trial testing a different gene therapy approach for sickle cell disease will soon be expanding to younger patients.
A clinical trial testing a different gene therapy approach for sickle cell disease will soon be expanding to younger patients.
After living with severe hemophilia B for decades, Julian hasn’t had a bleed or an infusion since his gene therapy at Stanford Medicine Children’s Health.
For Karar, living with beta thalassemia meant monthly infusions to keep his energy up, until gene therapy cured him.